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Background: Aquilaria crassna Pierre ex Lecomte has been traditionally used in Thailand for treatment of infectious
diseases such as diarrhoea and skin diseases for a long time. The main objectives of this study were to examine
antibacterial activity of the Aquilaria crassna leaf extract against Staphylococcus epidermidis and its underlying
mechanism. The antioxidant activity and acute toxicity were studied as well.
Methods: Antioxidant activities were examined by FRAP, ABTS and DPPH scavenging methods. Antibacterial
activity was conducted using disc diffusion assay and the minimum inhibitory concentration (MIC) was determined
by dilution method. The minimum bactericidal concentration (MBC) was reported as the lowest concentration
producing no growth of microbes in the subcultures. Morphological changes of the microbe were observed by
scanning electron microscopy, while an inhibitory effect on biofilm formation was evaluated by phase contrast
microscopic analysis. Bacterial cell wall integrity was assessed by transmission electron microscopy. Acute toxicity
was conducted in accordance with the OECD for Testing of Chemicals (2001) guidelines.
Results: The extract exhibited considerable antioxidant activity. Staphylococcus epidermidis was susceptible to the
extract with the MIC and MBC of 6 and 12 mg/ml, respectively. The extract caused swelling and distortion of
bacterial cells and inhibited bacterial biofilm formation. Rupture of bacterial cell wall occurred after treated with the
extract for 24 h. Acute toxicity test in mice showed no sign of toxicity or death at the doses of 2,000 and 15,000 mg/kg
body weight.
Conclusion: The aqueous extract of Aquilaria crassna leaves possesses an in vitro antibacterial activity against
Staphylococcus epidermidis, with no sign of acute oral toxicity in mice, probably by interfering with bacterial cell wall
synthesis and inhibiting biofilm formation.
Keywords: Aquilaria crassna, Staphylococcus epidermidis, Antioxidant, Anitbacterials, Cell wall, Acute toxicityIntroduction
Agarwood is mainly produced by trees in the species of
Aquilaria (family Thymelaeaceae). These plants provide
economically important natural products which are used
for the production of incense, perfumes and traditional
medicines in Asia [1]. At least four species of agarwood
trees are found in tropical rainforest areas of Thailand,* Correspondence: nuannoi@sut.ac.th
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distribution, and reproduction in any mediumnamely Aquilaria crassna Pierre ex Lecomte, A. subintegra,
A. malaccensis, and A. rugosa [2]. Owing to over-
exploitation, these plant species are nowadays considered
as endangered species of Southeast Asia. Therefore, culti-
vation of agarwood is encouraged to reduce the harvest
from wild populations. Since it takes about 10 years before
the wood can produce valuable essential oil or resin, leaves
from young agarwood are collected for production of
healthy tea in Viet Nam, Combodia and Thailand.
The agarwood extract has been used as one of the ac-
tive ingredients in several Thai traditional pharmaceut-
ical preparations, such as “Krisanaglun” which is used asCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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function enhancer in fainted patient. Based on Thai folk-
lore information, several parts of agarwood have been
used for a long time in the treatment of infectious diseases
such as diarrhoea, dysentery and skin diseases. Recently,
the antibacterial activities of A. crassna leaf extract against
enteric bacteria, such as Staphylococcus aureus, Clos-
toridium difficile, Peptostreptococcus anaerobius and
Bacteroides fragilis, have been reported [3]. However, its
inhibitory effect on S. epidermidis, the pathogen known to
cause skin disease and one of the most important oppor-
tunistic pathogens, has never been documented. In the
present study, the antibacterial activity against S.
epidermidis of the aqueous extract of A. crassna leaves and
possible mechanism were investigated. The phyto-
constiuents, antioxidant properties and acute toxicity of
the extract were studied as well.
Experimental procedures
Plant material
A. crassna leaves were collected from a cultivated field
in Nakhon Ratchasima province, Thailand. The plant
was identified by a botanist, Dr. Paul J. Grote, School of
Biology, Suranaree University of Technology (SUT) and
specimen of the plant has been kept at School of
Pharmacology, SUT. The voucher specimen number is
Pharm-Chu-005.
The leaves were oven dried at 50°C, and then cut into
small pieces. Dried leaves (24 g) were extracted in boil-
ing water (400 ml) for 30 min twice. The pooled extracts
were filtered and concentrated at 40°C using a rotary
evaporator under low pressure. The residue was freeze-
dried in a lyophilizer. The extract with a total yield of
14.2% was stored at −20°C until used.
Phytochemical screening
Phytochemical screening procedures were carried out
according to the standard methods previously reported
[4,5]. Qualitative phytochemical compositions of the
crude extract of Aquilaria crassna leaves were deter-
mined for the presence of alkaloids, flavonoids, tannins,
saponins and cardiac glycosides.
Determination of total phenolic compounds
The amount of total phenolic compounds was measured
by a method described by Matthaus [6]. In brief, 5 mg of
the extract was dissolved in 1 ml of distilled water. A
100 μl aliquot of this mixture was added to 2 ml of 2%
Na2CO3 followed by 100 μl of Folin-Ciocalteau reagent
in methanol (1:1 v/v). After 30 min of incubation, the
absorbance was measured at 750 nm. The concentration
was calculated using gallic acid as a standard. The re-
sults were expressed as milligrams gallic acid equivalents
(GAE) per gram extract.Determination of antioxidant activity
Scavenging effects on DPPH radicals
To measure antioxidant activity, the 2,2-diphenyl-1-
picrylhydrazyl hydrate (DPPH) radical scavenging assay
was carried out according to the procedure described
previously [7]. The crude extract (100 μl; final concen-
tration range from 0–50 μg/ml) was added to 4.0 ml of
50 μM DPPH in methanolic solution and the final vol-
ume was adjusted to 5.0 ml with water. After vortexing,
the mixture was incubated for 30 min in the dark at
room temperature. The decrease in absorbance at 517
nm was measured using a spectrophotometer. Antioxi-
dant activity was expressed as IC50, which was defined
as the concentration of the extract required to inhibit
the formation of DPPH radicals by 50%.
ABTS assay
ABTS (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)
radical-scavenging activity of extract was carried out
according to the procedure described previously [8].
ABTS radical cation (ABTS•+) was produced by the reac-
tion between 5 ml of 14 mM ABTS and 5 ml of 4.9 mM
potassium persulfate (K2S2O8). The resulting solution was
stored in the dark at room temperature for 16 h. Before
used, the solution was diluted with ethanol to give an ab-
sorbance of 0.700 ± 0.020 at 734 nm. The plant extract
(50 μl) at various concentrations were added to 950 μl of
ABTS solution and mixed thoroughly. The reaction mix-
ture was allowed to stand at room temperature for 6 min,
the absorbance was measured at 734 nm and compared to
the standard butylated hydroxytoluene (BHT).
Ferric reducing antioxidant power (FRAP) assay
The FRAP assay was conducted according to procedure
described by Dordevic et al. [9] with minor modification.
The FRAP reagent consists of 10 mM TPTZ (2,4,6-
tripyridyl-striazine) in 40 mM HCl, 20 mM FeCl3, and
300 mM acetate buffer (pH 3.6) in proportions of 1:1:10
(v/v/v). Fifty μl of the sample was added to 1.5 ml of
FRAP reagent (freshly prepared and warmed to 37°C be-
fore used). The absorbance was measured at 593 nm
using a UV spectrophotometer after 4 min of incubation.
A standard curve was constructed using FeSO4 solution.
The results were expressed as μmol Fe2+/mg dry weight
of plant material. All measurements were carried out in
triplicate and the mean values were calculated.
Antibacterial assays
Disc diffusion assay
The antibacterial activity of the crude extract was
assayed against S. epidermidis (obtained from Thailand
Institute of Scientific and Technological Research;
TISTR 518) using disc diffusion method previously de-
scribed [10]. Briefly, 100 μl of bacteria (108 CFU/ml) was
Table 1 Radical scavenging activities and reducing power
of the aqueous extract of A. crassna leaves
Methods
DPPH radical ABTS FRAP





7.25 ± 29.77 218.93 ± 29.77 1.18 ± 0.07
Ascorbic acid 1.33 ± 0.08 - -
Butylated
hydroxytoluene (BHT)
- 83.09 ± 0.45 -
Values are expressed as means ± standard deviation (n=3).
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(2, 4 and 6 mg) was applied to filter paper discs
(Whatman No. 1, 6 mm diameter) and then placed on
the previously inoculated agar plate. After 24 h of incu-
bation at 37°C, clear inhibition zones around the discs
indicated the presence of antibacterial activity. The assay
was carried out in triplicates. Vancomycin (30 μg) was
used as a positive control.
Determination of minimum inhibitory concentration (MIC)
and minimum bactericidal concentration (MBC)
Determination of the minimum inhibitory concentration
(MIC) against S. epidermidis (104 CFU/ml) was con-
ducted by a two-fold serial dilution method in Mueller-
Hinton broth (MHB). MIC was considered as the lowest
concentrations of the agents that yielded no visible
growth of microorganisms after 24 h of incubation at
37°C. The MBC determination was carried out by
subculturing 100 μl from each tube from the MIC assay
onto fresh substance-free MH agar plates. The MBC was
defined as the lowest concentration of agent that pro-
duced no growth of subcultures.
Biofilm assay
The inhibitory effect of the extract on biofilm formation
was examined by microscopic analysis. A culture of S.
epidermidis was prepared in tryptic soy broth (TSB) at
37°C for 24 h. 30 μl aliquots of the culture were pipetted
into each well of 24-well plates in the presence of 3 ml
TSB and incubated at 37°C for 24 h to form biofilm.
Thereafter, medium was replaced with fresh medium
containing the extract of A. crassna leaves or vanco-
mycin. After incubation of another 24 h, the medium
was removed and each well was gently washed three
times with phosphate buffer solution. The inhibitory ef-
fect on biofilm formation was observed by phase con-
trast microscopy.
Scanning electron microscopy
Scanning electron microscopy (SEM) was performed on
S. epidermidis treated with MIC of A. crassna leaf ex-
tract. S. epidermidis was cultured to reach mid-log phase
in MHB before use. Control and treated cells were pre-
pared for morphological observation. The bacterial sam-
ples were washed five times with fresh media and then
fixed with 2.5% glutaraldehyde in phosphate buffer (pH
7.2) at 4°C for 1 h, washed three times with phosphate
buffer for 10 min and fixed with 1% osmium tetroxide
for 2 h. This was followed by three washings in phos-
phate buffer for 10 min and subsequently dehydrated in
a series of ethanol concentrations (30%, 50%, 70%, 90%
and 95%), for 15 min each. The samples were subjected
to 100% ethanol and CO2 to achieve the critical point
and then coated with gold ion in a pressure metallicchamber. At the end of the process, the samples were
submitted for analysis by SEM.
Transmission electron microscopy
Cellular damage of bacteria was examined using trans-
mission electron microscopy (TEM). Bacterial cells
treated with vehicle, vancomycin and the extract of A.
crassna leaves were harvested after 24 h of incubation
and fixed in 2.5% glutaraldehyde in 0.1 M phosphate
buffer, for 2 h. The cells were washed three times with
0.05 M phosphate buffer (pH 7.2) and postfixed for 2 h
with 1% osmium tetroxide in 0.1 M phosphate buffer (pH
7.2) at room temperature. After washed twice in phos-
phate buffer, the cells were dehydrated through serial
graded concentrations of ethanol (35, 70, 95 and 100%, re-
spectively) for 15 min, then infiltrated and embedded in
Spurr’s resin. Ultrathin sections were cut with a diamond
knife using an ultramicrotome and then mounted on bare
copper grids. Finally, specimens were counterstained with
2% (w/v) for 3 min and then with 0.25% (w/v) lead citrate
solution for 2 min and examined with Tecnai G2 electron
microscope (FEI, USA) operated at 120 kV.
Acute toxicity in mice
The acute toxicity test performed in this experiment
was conducted by following the OECD guidelines for
Testing of Chemicals (2001) [11]. The aqueous extract
of A. crassna leaves was prepared in the concentrations
of 200 mg/ml and 750 mg/ml by dissolving in distilled
water for dosing group of 2,000 and 15,000 mg/kg body
weight respectively. All mice were monitored for clinical
signs of toxicity at 0.5, 1 and 3 h after oral administra-
tion of the extract and once daily thereafter for 14 days.
The organs of animals were removed immediately after
sacrificed on day 14 and then examined macroscopically
for pathological changes.
Statistical analysis
All experimental results were expressed as means ± stand-
ard deviation. The differences among groups in the acute
toxicity test were analyzed by one way ANOVA followed
Table 2 Antibacterial activity of the aqueous extract of







2 mg 4 mg 6 mg
Diameters of inhibition
zone (mm)
12.0 ±1.0 15.0 ± 0.4 18.0 ± 1.0 21.0 ± 1.0
MIC 6 mg/ml 1.5 μg/ml
MBC 12 mg/ml 3.0 μg/ml
Values are expressed as means ± standard deviation (n=3).
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0.05 were considered as statistically significant differences.
Results
Phytochemical screening, phenolic content and
antioxidant activity
Phytochemical analysis of the extract indicated the pres-
ence of flavonoids, tannins, saponins, cardiac glycosides
but the absence of alkaloids. Total phenolic content was
176.61 ± 24.46 mg GAE/g extract (n=3). The results of
radical scavenging capacities which were determined by
ABTS, FRAP and DPPH scavenging methods are shown
in Table 1. The IC50 of A. crassna leaf extract to scavenge
DPPH radical was 7.25 ± 2.05 μg/ml whereas that of as-
corbic acid was 1.33 ± 0.08 μg/ml. The IC50 values of
ABTS radical scavenging activity of the extract and the
standard BHT were 218.93 ± 29.77 μg/ml and 83.09 ±
0.45 μg/ml, respectively. The FRAP value of the extract
was 1.18 ± 0.07 μmol of Fe2+/mg dried extract.
Antibacterial activity
By disc diffusion assay, it was found that the extract
inhibited growth of Staphylococcus epidermidis (Table 2)
at 2, 4 and 6 mg. Vancomycin was employed as a positive
control. By macro-dilution method, the MIC and MBC of
the extract was 6 and 12 mg/ml, respectively.
Effects of the extract on biofilm formation
Crystal violet staining of surface-attached cells by micro-
titer plate assay is a popular and convenient method forFigure 1 Microscopic images on biofilm formation of S. epidermidis tr
(B) or the extract (C) formed less biofilm compared to control sample (A).quantitative detection of bacterial biofilm formation;
however direct microscopic observation is strongly rec-
ommended to confirm the data from staining analysis
[12]. Due to the absorption of the Aquilaria crassna leaf
extract at 595 nm, in the present study the effect on bio-
film formation was investigated by microscopic analysis
which gave more accurate imformation. The phase con-
trast microscopic images (Figure 1) showed that Staphylo-
coccus epidermidis formed vast empty regions on surface
with a few clusters of cells and scattering of single cell
when treated with the extract and vancomycin.
Morphological changes and rupture of bacterial cell wall
induced by the extract
Staphylococcus epidermidis was treated with the extract
at MIC (6 mg/ml) and incubated at 37°C for 24 and 48
h. SEM analyses were performed and compared to un-
treated and vancomycin-treated groups. Control bacteria
in the absence of the extract showed regular morphology
(Figure 2A), whereas cells treated with vancomycin
(Figure 2B) and the aqueous extract of A. crassna
leaves (Figure 2C) appeared swelling and distorting after
24 h of incubation. TEM monographs showed that vanco-
mycin and the extract caused rupture of bacterial cell wall
and alteration of bacterial shape compared to control
(Figure 3).
Acute oral toxicity of Aquilaria crassna leaf extract in mice
The acute toxicity of aqueous Aquilaria crassna leaf ex-
tract in mice is summarized in Table 3. The results
showed that with the doses of 2,000 and 15,000 mg/kg
body weight of the extract, all treated mice did not ex-
hibit abnormal signs of toxicity or deaths. Normal in-
crease in body weight and none of gross pathological
lesions were observed on the control and treated mice.
Discussion
There are several lines of evidence showing positive cor-
relation between total phenolic content and antioxidant
properties [13-15]. In addition to antioxidant activity,
plant phenolic compounds, such as flavonoids and tan-
nins, have been shown to possess antimicrobial activitieseated with A. crassna leaf extract. Cells treated with vancomycin
Enlargement: ×400.
Figure 2 Scanning electron micrograph of S. epidermidis treated with A. crassna leaves extract. Cells were treated as described in Material
and Method. The swollen cells (arrows) were observed after treated for 24 h with vancomycin (B) and the extract (C), compared with regular
shape of control (A). Enlargement: ×10000.
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to determine the antioxidant capacity in plant extracts
because of their simplicity, stability and accuracy [19].
As shown in Table 1, our results showed that the aque-
ous extract of A. crassna leaves exhibited substantial
antioxidant activity, suggesting its potential to possess
antimicrobital activity. Recently, a group of researchers
from Japan has reported antibacterial activities of the aque-
ous extract of A. crassna leaves against enteric bacteria,
such as S. aureus, Clostoridium difficile, Peptostreptococcus
anaerobius and Bacteroides fragilis [3]. Herein, we tested
its inhibitory effect on the Gram-positive bacteria using S.
epidermidis TISTR 518. This type of microorganism isFigure 3 Transmission electron micrograph of S. epidermidis treated w
untreated cells and cells treated with vancomycin and the extract, respecti
seen in both treated groups. Damaged cell walls (arrows) were observed a
compared with control (D). Enlargement: ×43000.one of coagulase-negative staphylococci which become in-
creasingly recognized as pathogen of nosocomial infection,
following ophthalmologic, neurologic and cardiothoracic
surgery, in immunocompromised patients and in patients
with prosthetic devices. This microbe was found suscep-
tible to the extract with MIC of 6 mg/ml, which is in the
range of MICs (4–8 mg/ml) against other bacterial strains
reported by Kakino and colleagues [3]. We further investi-
gated and found that the extract exhibited bactericidal ac-
tivity with MBC of 12 mg/ml.
The ability to form biofilm, a slimy layer with embed-
ded microcolonies, is one of the most important and
one of the most widespread virulence factors occurringith A. crassna leaves extract. A, B and C are overview of the
vely (Enlargement: ×15000). Bacterial cells with irregular shape were
fter 24 h of incubation with vancomycin (E) and the extract (F),
Table 3 Acute oral toxicity of the extract of A. crassna leaves in mice
Treatment (mg/kg) sex Body weight (g) Mortality Symtoms of toxicity Gross pathology
Day 1 Day 8 Day 15
0 33.20 ± 1.52 37.06 ± 1.52 41.00 ± 1.73 0 None Normal
2000 Male 32.80 ± 1.30 37.20 ± 0.84 41.00 ± 1.00 0 None Normal
15000 34.40 ± 1.14 39.80 ± 0.84 43.20 ± 0.84 0 None Normal
0 28.40 ± 1.67 30.80 ± 2.17 34.00 ± 1.58 0 None Normal
2000 Female 28.00 ± 1.22 30.00 ± 1.22 33.2 ± 1.64 0 None Normal
15000 28.80 ± 1.30 31.80 ± 1.30 34.00 ± 1.00 0 None Normal
Value are expressed as means ± standard deviation (n = 5); p> 0.05 compared to control.
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cial materials used for catheters and prosthetic devices
[20]; and it is estimated that biofilms are associated with
about 65% of nosocomial infections. It has been sug-
gested that biofilm formation is the main virulence
mechanism of S. epidermidis [21]. In addition to growth
inhibitory effect, the extract was found to impede the
production of slimy biofilm by S. epidermidis similar to
vancomycin which has been shown to inhibit S.
epidermidis biofilm formation [22].
It is widely accepted that plants are good sources of
novel antimicrobial agents. Screening of antimicrobial
activities to find which type of bacteria are susceptible to
plant extracts is useful, however the investigation of
underlying mechanism is also crucial for drug develop-
ment. To explore the possible antibacterial mechanism,
we studied the effect of the extract on morphological
changes of S. epidermidis cells by SEM and TEM.
Vancomycin, an antibiotic which is widely known to
damage bacterial cell wall of most Gram-positive bac-
teria, including staphylococci and enterococci, was used
as positive control. As revealed by SEM, bacterial cells
treated with aqueous extract of A. crassna leaves
appeared swelling and distorting after 24 h of incuba-
tion. Moreover, as evident by TEM monographs, the ex-
tract caused rupture of bacterial cell wall and alteration
of bacterial shape compared to control. It has been
reported that biofilm formation process consists of two
steps, of which the staphylococci first adhere to the
foreign-body surface and then accumulate into a com-
plex biofilm structure [23]. The interaction between spe-
cific adhesions located on cell wall and extracellular
matrix components deposit on the surface is essential
for the primary attachment. The destruction of cell wall
by the extract is likely to cause bacteria unable to grow
and create primary biofilm architecture.
A number of chemicals or plant extracts have shown
strong in vitro antimicrobial activities with low MIC,
however not all of them can be used in vivo due to their
high toxicity. Because the extract showed relatively high
MICs, the acute toxicity of aqueous A. crassna leafextract was investigated to assess its in vivo safety and
the results showed that all mice did not exhibit abnor-
mal signs of toxicity or deaths after receiving the extract
even at high dose (15,000 mg/kg body weight).Conclusion
The present study has reported the screening phyto-
chemistry, total phenolic content, and antioxidant activ-
ities of the aqueous extract of A. crassna leaves. More
importantly, the antibacterial activity and inhibitory ef-
fect on biofilm formation of the extract against S.
epidermidis were demonstrated. The postulated under-
lying mechanism was disruption of bacterial cell wall. In
addition, high dose of the extract showed the absence of
acute oral toxicity in mice. The data also suggest that A.
crassna may be a potential source for the discovery of
new antibacterial agents against S. epidermidis and prob-
ably other Gram-positive bacteria as well.
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